Perineal talc exposure and epithelial ovarian cancer risk in the central valley of California

Paul K. Mills, Deborah G. Riordan, Rosemary D Cress, Heather A. Young

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Perineal talc use has been suggested as a possible risk factor for ovarian cancer based on its structural similarity to asbestos, a known human carcinogen. A population-based epidemiologic case-control study of epithelial ovarian cancer (EOC) was conducted in 22 counties of Central California that comprise the reporting area for 2 regional cancer registries. Telephone interviews were conducted with 256 cases diagnosed in the years 2000-2001 and 1,122 controls frequency-matched on age and ethnicity. The interview obtained information on demographic factors, menstrual and reproductive experience, exogenous hormone use, surgical history and family history of cancer. Questions on perineal talc use included frequency of use, duration of use and specific years when talc was used. Multivariate-adjusted odds ratio (OR) and 05% confidence intervals (CI) were derived from unconditional logistic regression. The OR for ever use of talc was 1.37 (CI = 1.02-1.85) compared to never users. However, no dose response association was found. Tubal ligation (TL) modified the effect of talc on EOC such that women with TL had an OR of 0.88 (CI = 0.46-1.68) associated with perineal talc use, whereas women with no TL had an OR of 1.54 (CI = 1.10-2.16). Talc use and EOC risk was highest in women with serous invasive tumors (OR = 1.77; CI = 1.12-2.81). This study provides some support for the hypothesis that perineal talc use is associated with an increased risk of EOC.

Original languageEnglish (US)
Pages (from-to)458-464
Number of pages7
JournalInternational Journal of Cancer
Volume112
Issue number3
DOIs
StatePublished - Nov 10 2004

Fingerprint

Talc
Tubal Sterilization
Odds Ratio
Confidence Intervals
Interviews
Neoplasms
Ovarian epithelial cancer
Asbestos
Carcinogens
Ovarian Neoplasms
Registries
Case-Control Studies
Logistic Models
History
Demography
Hormones

Keywords

  • Epidemiology
  • Gynecologic cancer
  • Risk factors

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Perineal talc exposure and epithelial ovarian cancer risk in the central valley of California. / Mills, Paul K.; Riordan, Deborah G.; Cress, Rosemary D; Young, Heather A.

In: International Journal of Cancer, Vol. 112, No. 3, 10.11.2004, p. 458-464.

Research output: Contribution to journalArticle

Mills, Paul K. ; Riordan, Deborah G. ; Cress, Rosemary D ; Young, Heather A. / Perineal talc exposure and epithelial ovarian cancer risk in the central valley of California. In: International Journal of Cancer. 2004 ; Vol. 112, No. 3. pp. 458-464.
@article{551f8098b2434f2ba0f6c7e502178996,
title = "Perineal talc exposure and epithelial ovarian cancer risk in the central valley of California",
abstract = "Perineal talc use has been suggested as a possible risk factor for ovarian cancer based on its structural similarity to asbestos, a known human carcinogen. A population-based epidemiologic case-control study of epithelial ovarian cancer (EOC) was conducted in 22 counties of Central California that comprise the reporting area for 2 regional cancer registries. Telephone interviews were conducted with 256 cases diagnosed in the years 2000-2001 and 1,122 controls frequency-matched on age and ethnicity. The interview obtained information on demographic factors, menstrual and reproductive experience, exogenous hormone use, surgical history and family history of cancer. Questions on perineal talc use included frequency of use, duration of use and specific years when talc was used. Multivariate-adjusted odds ratio (OR) and 05{\%} confidence intervals (CI) were derived from unconditional logistic regression. The OR for ever use of talc was 1.37 (CI = 1.02-1.85) compared to never users. However, no dose response association was found. Tubal ligation (TL) modified the effect of talc on EOC such that women with TL had an OR of 0.88 (CI = 0.46-1.68) associated with perineal talc use, whereas women with no TL had an OR of 1.54 (CI = 1.10-2.16). Talc use and EOC risk was highest in women with serous invasive tumors (OR = 1.77; CI = 1.12-2.81). This study provides some support for the hypothesis that perineal talc use is associated with an increased risk of EOC.",
keywords = "Epidemiology, Gynecologic cancer, Risk factors",
author = "Mills, {Paul K.} and Riordan, {Deborah G.} and Cress, {Rosemary D} and Young, {Heather A.}",
year = "2004",
month = "11",
day = "10",
doi = "10.1002/ijc.20434",
language = "English (US)",
volume = "112",
pages = "458--464",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Perineal talc exposure and epithelial ovarian cancer risk in the central valley of California

AU - Mills, Paul K.

AU - Riordan, Deborah G.

AU - Cress, Rosemary D

AU - Young, Heather A.

PY - 2004/11/10

Y1 - 2004/11/10

N2 - Perineal talc use has been suggested as a possible risk factor for ovarian cancer based on its structural similarity to asbestos, a known human carcinogen. A population-based epidemiologic case-control study of epithelial ovarian cancer (EOC) was conducted in 22 counties of Central California that comprise the reporting area for 2 regional cancer registries. Telephone interviews were conducted with 256 cases diagnosed in the years 2000-2001 and 1,122 controls frequency-matched on age and ethnicity. The interview obtained information on demographic factors, menstrual and reproductive experience, exogenous hormone use, surgical history and family history of cancer. Questions on perineal talc use included frequency of use, duration of use and specific years when talc was used. Multivariate-adjusted odds ratio (OR) and 05% confidence intervals (CI) were derived from unconditional logistic regression. The OR for ever use of talc was 1.37 (CI = 1.02-1.85) compared to never users. However, no dose response association was found. Tubal ligation (TL) modified the effect of talc on EOC such that women with TL had an OR of 0.88 (CI = 0.46-1.68) associated with perineal talc use, whereas women with no TL had an OR of 1.54 (CI = 1.10-2.16). Talc use and EOC risk was highest in women with serous invasive tumors (OR = 1.77; CI = 1.12-2.81). This study provides some support for the hypothesis that perineal talc use is associated with an increased risk of EOC.

AB - Perineal talc use has been suggested as a possible risk factor for ovarian cancer based on its structural similarity to asbestos, a known human carcinogen. A population-based epidemiologic case-control study of epithelial ovarian cancer (EOC) was conducted in 22 counties of Central California that comprise the reporting area for 2 regional cancer registries. Telephone interviews were conducted with 256 cases diagnosed in the years 2000-2001 and 1,122 controls frequency-matched on age and ethnicity. The interview obtained information on demographic factors, menstrual and reproductive experience, exogenous hormone use, surgical history and family history of cancer. Questions on perineal talc use included frequency of use, duration of use and specific years when talc was used. Multivariate-adjusted odds ratio (OR) and 05% confidence intervals (CI) were derived from unconditional logistic regression. The OR for ever use of talc was 1.37 (CI = 1.02-1.85) compared to never users. However, no dose response association was found. Tubal ligation (TL) modified the effect of talc on EOC such that women with TL had an OR of 0.88 (CI = 0.46-1.68) associated with perineal talc use, whereas women with no TL had an OR of 1.54 (CI = 1.10-2.16). Talc use and EOC risk was highest in women with serous invasive tumors (OR = 1.77; CI = 1.12-2.81). This study provides some support for the hypothesis that perineal talc use is associated with an increased risk of EOC.

KW - Epidemiology

KW - Gynecologic cancer

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=6344277421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=6344277421&partnerID=8YFLogxK

U2 - 10.1002/ijc.20434

DO - 10.1002/ijc.20434

M3 - Article

C2 - 15382072

AN - SCOPUS:6344277421

VL - 112

SP - 458

EP - 464

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 3

ER -